Differential activity of P-glycoprotein in normal blood lymphocyte subsets

British Journal of Haematology

Volumn 101, Issue 4, 1998, Pages 722-727

  Ludescher, Christof ^a   Pall, Georg ^a   Irschick, Eveline U ^a   Gastl, Günther ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Flow cytometry; Lymphocytes; Multidrug resistance; P glycoprotein; Rhodamine 123

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CHROMIUM 51; DEXNIGULDIPINE; GLYCOPROTEIN P; LYMPHOCYTE ANTIGEN; RHODAMINE 123; VERAPAMIL;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROLEUKEMIA CELL; GRANULOCYTE; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MONOCYTE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TARGET CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; KILLER CELLS, NATURAL; P-GLYCOPROTEIN; RHODAMINE 123; RHODAMINES; T-LYMPHOCYTE SUBSETS;

EID: 0031802858     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00751.x     Document Type: Article

References (32)

1. Akbar, A.N., Salmon, M. & Janossy, G. (1991) The synergy between naive and memory T cells during activation. Immunology Today, 12, 184-188.
2. Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troney, J., Treille, D. & Fiere, D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood, 79, 473-476.
3. Chaudhary, P.M., Mechetner, E.B. & Roninson, I.B. (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood, 80, 2735-2739.
4. Chaudhary, P.M. & Roninson, I.B. (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 66, 85-94.
5. Chong, A.S., Markham, P.N., Gebel, H.M., Bines, S.D. & Coon, J.S. (1993) Diverse multidrug resistance modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunology and Immunotherapy, 36, 133-139.
6. Drach, J., Gsur, A., Hamilton, G., Zhao, S., Angerler, J., Fiegl, M., Zojer, N., Raderer, M., Haberl, I., Andreeff, M. & Huber, H. (1996) Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-γ in normal human T lymphocytes. Blood, 88, 1747-1754.
7. Feller, N., Kuiper, C.M., Lankelma, J., Ruhdal, J.K., Scheper, R.J., Pinedo, H.M. & Broxterman, H.J. (1995) Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. British Journal of Cancer, 72, 543-549.
8. Fox, B., Lewis, D., Deemer, K., El Masry, M. & Rich, R. (1987) T suppressor cell growth factor and anti-CD3 antibodies stimulate reciprocal subsets of T lymphocytes. Journal of Experimental Medicine, 166, 404-418.
9. Goasguen, J.E., Dossot, J.M., Fardel, O., Le Mee, F., Le Gall, E., Leblay, R., LePrise, P.Y., Chaperon, J. & Fuachet, R. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood, 81, 2394-2398.
10. Gottesman, M.M., Willingham, M.C., Thiebaut, F. & Pastan, I. (1991) Expression of the MDR1 gene in normal human tissue. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. Plenum Press, New York.
11. Gros, P., Croop, J. & Housman, D. (1986) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell, 47, 371-380.
12. + T cells: a role in cytotoxic effector function. Journal of Clinical Immunology, 12, 451-458.
13. Hofman, J., Ueberall, F., Egle, A. & Grunicke, H. (1991) B-859-35 a new drug with anti-tumor activity reverses multi-drug resistance. International Journal of Cancer, 47, 870-874.
14. Hollt, V., Kouba, M., Dietel, M. & Vogt, G. (1992) Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-gp. Biochemical Pharmacology, 43, 2601-2608.
15. + T cells from CD45RA to CD45RO is accompanied by cell activation and proliferation. Cytometry, 19, 343-352.
16. Klimecki, W.T., Futscher, B.W., Grogan, T.M. & Dalton, W.S. (1994) P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood, 83, 2451-2458.
17. Kobayashi, Y., Yamashiro, T., Watanabe, N., Tanaka, H., Shigenobu, H. & Tsuruo, T. (1994) Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell population revealed by MRK-16 monoclonal antibody and AHC-52. Biochemical Pharmacology, 48, 1641-1646.
18. Ludescher, C., Eisterer, W., Hilbe, W., Gotwald, M., Hofmann, J., Zabernigg, A., Cianfriglia, M. & Thaler, J. (1995a) Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia. Leukemia, 9, 350-356.
19. Ludescher, C., Eisterer, W., Hilbe, W., Hofman, J. & Thaler, J. (1995b) Decreased potency of MDR-modulators under serum conditions determined by a functional assay. British Journal of Haematology, 91, 652-657.
20. Ludescher, C., Hilbe, W., Eisterer, W., Preuss, E., Huber, C., Gotwald, M., Hofmann, J. & Thaler, J. (1993) Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay. Journal of the National Cancer Institute, 85, 1751-1758.
21. Ludescher, C., Thaler, J., Drach, D., Drach, J., Spitaler, M., Gattringer, C., Huber, H. & Hofmann, J. (1992) Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. British Journal of Haematology, 82, 161-168.
22. Mackay, C.R. (1991) T-cell memory: the connection between function, phenotype and migration pathways. Immunology Today, 12, 189-192.
23. Nooter, K. & Sonneveld, P. (1994) Clinical relevance of P-glycoprotein in hematological malignancies. Leukemia Research, 18, 233-243.
24. Pastan, I. & Gottesman, M. (1987) Multiple-drug resistance in human cancer. New England Journal of Medicine, 316, 1388-1393.
25. Picker, L.J., Singh, M.K., Zdraveski, Z., Treer, J.R., Waldrop, S.L., Berstresser, P.R. & Maino, C. (1995) Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood, 86, 1408-1419.
26. Robertson, M.J. & Ritz, J. (1990) Biology and clinical relevance of human natural killer cells. Blood, 76, 2421-2438.
27. Rubbert, A., Manger, B., Lang, N., Kalden, J.R. & Platzer, E. (1991) Functional characterization of tumor-infiltrating lymphocytes. lymph node lymphocytes and peripheral blood lymphocytes from patients with breast cancer. International Journal of Cancer, 49, 25-31.
28. Tajima, F., Kawatani, T., Endo, A. & Kawasaki, H. (1996) Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia. Leukemia, 10, 478-482.
29. Trowbridge, I.S. & Thomas, M.L. (1994) CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annual Review of Immunology, 12, 85-116.
30. Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T. & Hori, R. (1992) Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. Journal of Biological Chemistry 34, 24248-24252.
31. Weinstein, R.S., Kuszak, J.R., Kluskens, L.F. & Coon, J.S. (1990) P-glycoprotein in pathology: the multidrug resistance gene family in humans. Human Pathology, 21, 34-48.
32. Yuen, A.R. & Sikic, B.I. (1994) Multidrug resistance in lymphomas. Journal of Clinical Oncology, 12, 2453-2460.